酸糖蛋白手性柱分离6种手性化合物

通过考察缓冲液种类、浓度及其pH值对对映体在手性柱上的保留和分离行为的影响,以及流动相中加入不同种类、不同浓度的不带电荷的有机溶剂乙腈、甲醇、正丙醇、异丙醇、流动相流速和柱温对对映体分离能力的影响,优化了含碳手性中心的碱性药物苯丙哌林、酸性化合物MT-A5及MT-酸和含硫手性中心的质子泵抑制剂奥美拉唑、泮托拉唑、雷贝拉唑对映体分离条件,最佳手性分离条件为:苯丙哌林,0.05 mol/L磷酸二氢铵缓冲液(pH 3.0)-乙腈(95∶5,V/V)为流动相,流速为0.7 mL/m in,柱温为20℃;MT-A5及MT-酸,流动相为0.01 mol/L醋酸铵缓冲液(pH 5.0)-乙腈(74∶26,V/V),流速为0.9 mL/m in,柱温为20℃;泮托拉唑,流动相为10 mmol/L醋酸铵缓冲液(pH 5.5)-乙腈(93∶7,V/V),流速为0.9 mL/m in;柱温为20℃;奥美拉唑和雷贝拉唑,流动相为0.01 mol/L醋酸铵缓冲液(pH 3.0)-乙腈(95∶5,V/V),流速为0.7 mL/m in,柱温为20℃。实现了应用高效液相色谱法在α1-酸糖蛋白手性柱上对上述化合物的对映体分离,并成功用于手性药物合成中的对映体过量百分率的测定。     

高效液相色谱-串联质谱法结合多糖衍生物手性固定相拆分氰戊菊酯

建立了以多糖衍生物为手性固定相的高效液相色谱-串联质谱(HPLC-MS/MS)直接拆分氰戊菊酯对映体的方法。在反相液相色谱条件下,考察了手性固定相的种类、流动相组成、柱温、流速对氰戊菊酯4个立体异构体分离的影响。同时,利用热力学方法对氰戊菊酯的立体异构体与固定相之间的色谱保留和分离的热力学机理进行了探讨。结果表明:采用Lux Cellulose-3(纤维素-三(4-甲基苯甲酸酯))手性色谱柱,在以流动相为乙腈-水(5 mmol/L甲酸铵)=(55:45,V:V)流速0.4 mL/min,柱温30℃的条件下,可在14 mins内实现氰戊菊酯4个立体异构体的基线分离。拓展了HPLC-MS/MS在菊酯类手性农药对映体分离及检测上的应用。     

α-酸糖蛋白手性柱对56种手性化合物的拆分

采用α-酸糖蛋白手性固定相(Chiral-AGP),固定流动相pH、流速,化合物样品浓度,考察酸性、碱性、中性手性化合物和21个氨基酸在α-酸糖蛋白手性柱上的拆分情况.应用高效液相色谱法,α-酸糖蛋白手性柱对上述手性样品拆分,一共有8个中性化合物、3个碱性化合物、6个酸性化合物和5个氨基酸得到手性对映分离.探讨了α-酸糖蛋白手性柱对酸性、中性、碱性样品的拆分能力并进行对比,结果证明α-酸糖蛋白手性柱拆分中性化合物和酸性化合物效果最好,拆分碱性化合物和氨基酸效果不好,为α-酸糖蛋白手性柱适合于拆分哪一类型的手性化合物提供参考.     

使用大环糖肽抗生素键合固定相高效液相色谱法直接拆分卡巴拉汀

采用高效液相色谱法在大环糖肽抗生素键合固定相手性柱上拆分了卡巴拉汀(Rivastigmine)对映体。考察了甲醇∶乙酸∶三乙胺流动相体系中乙酸和三乙胺的浓度和比例、有机酸的种类、分离温度及流动相流速对拆分结果的影响。选定的色谱条件为:Chirobiotic V手性柱(250mm×4.6mmi.d.,5μm),流动相为V(甲醇)∶V(乙酸)∶V(三乙胺)=100∶0.02∶0.01,柱温5℃,流速0.5mL/min,检测波长274nm。在柱温5~30℃范围内测定lnα与1/T呈线性关系:lnα=ΔΔH0/RT ΔΔR0/R。     

高效液相色谱法手性拆分(2-戊基-3-苯基-2,3环氧丙烷基)二苯基磷酸酯对映体

采用多糖类手性色谱柱,建立了(2-戊基-3-苯基-2,3环氧丙烷基)二苯基磷酸酯对映体的高效液相色谱手性拆分方法。考察了手性柱类型、流动相组成、流速、柱温等对手性拆分的影响,并对分离机制进行了探讨。结果表明,采用Chiralpak AS-H柱(250×4.6mm,i.d.,5μm),以正己烷-异丙醇(85∶15,V/V)为流动相,在柱温25℃,流速1.0mL/min,检测波长210nm的条件下,(2-戊基-3-苯基-2,3环氧丙烷基)二苯基磷酸酯对映体能达到完全分离,且稳定性和重复性好。该方法也适用于(2-戊基-3-苯基-2,3环氧丙烷基)二苯基磷酸酯类似物的手性拆分。     

手性流动相HPLC法拆分对羟基苯甘氨酸对映体的研究

将β-环糊精、羟丙基-β-环糊精作为手性流动相添加剂,系统地研究了D,L对羟基苯甘氨酸在RP-HPLC系统中的拆分。分别考察了手性流动相的种类,手性试剂β-环糊精的浓度,流动相的pH,修饰剂的种类及浓度,色谱柱温度等对拆分效果的影响,以-βCD为手性流动相添加剂,建立了-βCD手性流动相分离对羟基苯甘氨酸对映体的方法。结果表明:用ODS柱(250 mm×4.6 mmi.d.),以V(甲醇-β环糊精)∶V(pH 4.5磷酸盐缓冲液)=30∶70为流动相,流速0.2 mL/min,柱温25℃,检测波长为230 nm时对羟基苯甘氨酸对映体得到了良好的基线分离,分离度可达1.71。     

联萘系列化合物在甘氨酸型手性固定相上的拆分

探讨了7个联萘化合物在甘氨酸型手性固定相上的拆分,考察了流动相组成、柱温等对保留及手性拆分的影响,结合计算得到的热力学参数对手性识别机理进行了探讨.联萘酚及溴代联萘酚在该固定相上得到了良好的分离,其2个醚类衍生物得到了部分拆分,而3个酯类衍生物完全无法分离.拆分过程为焓驱动,酚羟基对提高二异构体与手性固定相之间的作用差异起关键作用.     

大环抗生素手性固定相拆分克伦普罗对映体及分离机制研究

应用三种大环抗生素类手性固定相Chirobiotic V、Chirobiotic T和Chirobiotic R,采用高效液相色谱法对盐酸克伦普罗对映体进行了拆分研究。实验考察了洗脱模式、流动相组成、柱温等因素对分离的影响,对分离结果进行了比较,并对其分离机制进行了探讨。结果表明,盐酸克伦普罗对映体在Chirobiotic R手性固定相上不能实现分离,在Chirobiotic V和Chirobiotic T手性固定相上,最佳色谱条件为:新极性有机相模式,流动相为甲醇-乙酸-三乙胺(100∶0.01∶0.01,V/V/V),流速:1.0mL/min,柱温:20℃,分离度可分别达到2.00和2.13。实验证明,盐酸克伦普罗对映体与大环抗生素类固定相之间的离子相互作用是实现对映体分离的最主要分离机制。     

大环抗生素手性固定相拆分盐酸马布特罗对映体

基于三种大环抗生素类手性固定相Chirobiotic V,T和R,利用高效液相色谱法对盐酸马布特罗对映体进行了拆分;考察了洗脱模式、流动相组成、柱温等因素对分离的影响,对分离结果进行了比较,对分离机制进行了探讨.结果表明,盐酸马布特罗对映体在Chirobiotic R手性固定相上不能实现分离,在Chirobiotic V和T手性固定相上均可实现较好的基线分离.最佳色谱条件为:新极性有机相模式,流动相甲醇-冰醋酸-三乙胺(100∶0.01∶0.01,V/V/V),流速1.0mL/min,柱温20℃;相应的分离度分别可达3.08和3.73.与此同时,盐酸马布特罗对映体与大环抗生素类固定相之间的离子相互作用是实现对映体分离的最主要分离机制.     

低温条件对高效液相色谱手性拆分柱效和选择性的影响

本文研究了低温条件下温度对高效液相色谱手性拆分的影响。以消旋安息香为样品,以正己烷-乙醇(70∶30,V/V)为流动相,分别用粒径为3μm、5μm、10μm的Chiralcel OD手性柱,分别在-40℃、-25℃、-10℃、5℃、20℃、35℃柱温条件下,测定了不同流速下安息香手性拆分的保留时间和柱效。根据van Deemter方程对每个温度条件下的H-u关系图进行非线性拟合,得到A、B和C三个系数与温度的关系曲线。根据手性拆分的热力学关系式,在-40℃到35℃柱温范围内,考察各色谱柱对安息香分离的lnk2′-1/T、lnα-1/T的关系均为线性。结果显示,在整个实验温度范围内,安息香在Chiralcel OD手性柱的手性拆分机理不变,降低温度能提高手性分离的选择性,但是会降低通常流速下的柱效,从而影响分离度。随着温度的降低,各色谱柱得到的van Deemter方程中系数A基本不变,系数C随着温度降低逐渐升高。     

酸催化的二芳基甲醇脱水环化氧化芳构化直接构筑4-芳基喹啉

我们发展了酸催化的二芳基甲醇的脱水环化氧化芳构化的方法,直接高产率（高达81%）的合成轴手性的4-芳基喹啉.而且,Lewis酸Zn（OTf）₂和手性膦酸都能催化这个反应,初步的不对称研究可以用er 71：29得到产物.     

双手性选择单元手性固定相的研究进展

手性固定相（chiral stationary phase,CSP）作为手性色谱分离的核心技术,在手性化合物的识别和分离中得到广泛应用。以双手性选择单元结合作为CSP是近些年的研究热点,研究表明,两种手性选择单元相结合的CSP可增加手性识别位点,显著提高分离效果。本文介绍了近几年双手性选择单元手性固定相在手性分离中的研究进展,并对其发展前景进行了展望。     

Simultaneous chiral analyses of multiple analytes: case studies, implications and method development considerations

The field of chiral separations had a modest beginning some two decades ago. However, due to rapid technological advancement coupled with simultaneous availability of innovative chiral stationary phases and novel chiral derivatization agents, the field of chiral separations has now totally outpaced many other separation fields. Keeping pace with rapid changes in the field of chiral separations, investigators continue to add stereoselective pharmacokinetic, pharmacodynamic, pharmacologic and toxicological data of new and/or marketed racemic compounds to the literature. Examination of the evolution of chiral separations suggests that in the beginning many investigators attempted to separate and quantify a single pair of enantiomers, adopting either direct (separation made on a chiral stationary phase) or indirect (separation made following precolumn conversion of enantiomers to corresponding diastereomers) approaches. However, more recent trends in chiral separations suggest that investigators are attempting to separate and quantify multiple pairs of enantiomers with available technologies. Added to this, some interesting trends have been observed in many of the recently reported chiral applications, including preferences regarding internal standard selection, mobile phase contents and composition, sorting out issues with mass spectrometric detection, determination of elution order, analytical manipulations of metabolite(s) without reference standards and addressing some specificity-related issues. This review mainly focuses on chiral separations involving multiple chiral analytes and attempts to justify the need for such chiral separations involving multiple analytes. In this context, several cases studies are described on the utility and applicability of such chiral separations under discrete headings to provide an account to the readership on the implications of such tasks. The topics of case studies covered in this review include: (a) therapy markers--differentiation from drug abuse and/or applicability in forensics; (b) role in pharmacogenetic/polymorphic evaluation; (c) monitoring and understanding the role of parent and active metabolite(s) in clinical and preclinical investigations; (d) exploration on the pharmacokinetic utility of an active chiral metabolite vis-a-vis the racemic parent moiety; (e) understanding the chirality play in delineating peculiar toxic effects; (f) exploration of chiral inversion phenomenon, and understanding the role of stereoselective metabolism. For the further benefit of readership, some select examples (n = 19) of the separation of multiple chiral analytes with appropriate information on chromatography, detection system, validation parameters and applicable conclusion are also provided. Finally, the review covers some useful considerations for method development involving multiple chiral analytes.     

16种手性化合物在不同自制手性固定相上的拆分比较

采用高效液相色谱法,在自制的纤维素-三(3,5-二甲基苯基氨基甲酸酯)(ATEO-OD)、纤维素-三(4-甲基苯基氨基甲酸酯)(ATEO-OG)和纤维素-三(4-甲基苯基甲酸酯)(ATEO-OJ)3种手性柱上对16种不同结构的手性化合物进行了拆分和比较.试验结果表明:16个手性样品在这3种手性固定相上分别获得了不同程度的拆分,A TEO-OD对所分析样品具有更好的手性识别能力,ATEO-OG和ATEO-OJ的手性识别能力相当.     

Last ten years (2008–2018) of chiral ligand‐exchange chromatography in HPLC: An updated review

Chiral ligand‐exchange chromatography is one of the elective strategies for the direct enantioresolution of small chelating compounds: amino acids, diamines, amino alcohols, diols, small peptides, etc. Unlike other methods, the interaction between chiral selector and analyte enantiomers is mediated by a cation, thus producing diastereomeric ternary complexes. Two main approaches are conventionally applied in chiral ligand‐exchange chromatography. The first relies upon chiral stationary phases where the chiral selector is either covalently immobilized or physically adsorbed onto suitable packing materials (coated phases). In the second approach, chiral molecules are added to the eluent, thus generating chiral eluent systems. Among the advantages of chiral ligand‐exchange chromatography, the generation of UV/vis‐active metal complexes, and the use of commercially available or easy‐to‐synthesize chiral selectors, in combination to rather inexpensive achiral columns for coated phases and chiral eluents, are noteworthy. Besides amino acids and amino alcohols, other species have proven suitable for chiral ligand‐exchange chromatography applications. Recently, the use of either chiral ionic liquids or micellar liquid chromatography systems as well as the successful off‐column formation of diastereomeric complexes have expanded the selectivity profiles and application fields. All of these issues are touched in the review, shedding light to the contributions appeared in the last decade.     

环境中手性污染物对映体分析方法的研究进展

手性污染物对映体尽管具有相似的物理化学性质,但在环境中的吸附、转移、降解等过程往往存在一定差异。生态安全问题与人类健康密切相关,因此,对手性环境污染物进行对映体水平上的分离分析是十分重要的研究课题。目前,国内外对环境中的手性污染物已开展了相关研究,然而全面评述相关分析测定方法的新进展鲜有报道。本文主要对环境中手性污染物的种类以及近5年环境中手性污染物的分析检测技术如液相色谱-质谱联用法、气相色谱-质谱联用法、毛细管电泳法、超临界流体色谱-质谱联用法等进行了归纳、综述和展望,为后续手性污染物的分析检测提供依据和参考。     

手性2-(口恶)唑烷酮的无溶剂合成法

在无溶剂条件下,手性的β-氨基醇和脲在160-180℃反应0．5-1 h,在200℃反应0．5 h,高产率地获得手性噁唑烷酮。     

手性2-噁唑烷酮的无溶剂合成法

手性2-噁唑烷酮的无溶剂合成法;手性氨基醇;脲;手性噁唑烷酮     

Methods of studies on quantitative structure–activity relationships for chiral compounds

Chiral compounds are very important in drug development, organic synthesis, materials science, toxicology, or environmental chemistry. Therefore, for creating new drugs, several methods have been suggested in recent years. In several laboratories in the world, some new methods for the derivations of the parameters were constructed and used for studies on quantitative structure–activity/property relationships of chiral molecules. The algorithms reviewed in this paper involve Zargeb group chiral indices, chiral molecular connectivity index, chiral topological charge index, chiral A_m index, chiral indices based on the matrixes, chiral indices based on chiral product, conformation‐independent chirality code, conformation‐dependent chirality code, quantitative two‐dimensional chirality degrees of benzenoids, and so on. Copyright © 2012 John Wiley & Sons, Ltd.